Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 1 | -$0.98 | -$0.98 | -$0.98 |
Q2 2025 | 1 | -$0.76 | -$0.76 | -$0.76 |
Q3 2025 | 1 | -$0.46 | -$0.46 | -$0.46 |
Q4 2025 | 1 | -$0.64 | -$0.64 | -$0.64 |
Arcadia Biosciences, Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.87 earnings per share for the quarter, missing analysts' consensus estimates of $-0.77 by $0.1. The company had revenue of 1.54 M for the quarter and had revenue of 5.33 M for the year. Arcadia Biosciences, Inc. has generated $-11 earnings per share over the last year ($-11.3 diluted earnings per share) and currently has a price-to-earnings ratio of -1.16. Arcadia Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/12/2024 | Q3 2024 | -$0.77 | -$1.18 | -0.41 | $1.40 M | $1.54 M |
08/13/2024 | Q2 2024 | $1.55 | $0.78 | -0.77 | $950,000 | $1.31 M |
05/13/2024 | Q1 2024 | -$1.78 | $1.26 M | |||
04/29/2024 | Q4 2023 | -$2.22 | $1.17 M | |||
11/09/2023 | Q3 2023 | -$2.67 | -$1.89 | 0.78 | $1.55 M | $1.60 M |
08/10/2023 | Q2 2023 | -$4.92 | $0.60 | 5.52 | $1.60 M | $1.39 M |
05/15/2023 | Q1 2023 | -$6.35 | -$4.45 | 1.9 | $1.51 M | |
03/30/2023 | Q4 2022 | $6.80 | -$7.03 | -13.83 | $1.00 M | |
11/10/2022 | Q3 2022 | -$7.60 | -$4.82 | 2.78 | $2.67 M | $1.88 M |
08/11/2022 | Q2 2022 | -$12.40 | -$6.81 | 5.59 | $2.30 M | $3.86 M |
05/12/2022 | Q1 2022 | -$12.40 | -$8.07 | 4.33 | $3.22 M | |
03/31/2022 | Q4 2021 | -$0.42 | $2.17 M | |||
11/15/2021 | Q3 2021 | -$9.20 | -$4.00 | 5.2 | $2.51 M | $2.38 M |
08/16/2021 | Q2 2021 | -$9.20 | -$9.68 | -0.48 | $1.69 M | $1.41 M |
05/17/2021 | Q1 2021 | -$12.40 | $4.40 | 16.8 | $828,000 | |
03/31/2021 | Q4 2020 | $0.83 | $7.13 M | |||
11/13/2020 | Q3 2020 | -$23.85 | $1.14 M | $314,000 | ||
08/13/2020 | Q2 2020 | -$24.40 | -$41.55 | -17.15 | $1.86 M | $281,000 |
05/13/2020 | Q1 2020 | -$19.20 | $11.60 | 30.8 | $309,000 | |
03/25/2020 | Q4 2019 | -$24.40 | -$0.72 | 23.68 | $416,000 |
Arcadia Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based off last year's report dates.
The conference call for Arcadia Biosciences, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Arcadia Biosciences, Inc.'s latest earnings report can be read online.
Arcadia Biosciences, Inc. (:RKDA) has a recorded annual revenue of $5.33 M.
Arcadia Biosciences, Inc. (:RKDA) has a recorded net income of $5.33 M. Arcadia Biosciences, Inc. has generated $-11.3 earnings per share over the last four quarters.
Arcadia Biosciences, Inc. (:RKDA) has a price-to-earnings ratio of -1.16 and price/earnings-to-growth ratio is -0.08.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED